Susquehanna International Group
CYTO

Susquehanna International Group’s Altamira Therapeutics Ltd CYTO Stock Holding History

Susquehanna International Group’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-509
Closed -$2.46K – 13708
2023
Q3 		$2.46K Buy
+509
New +$3.61K ﹤0.01% 11831
2022
Q3 		– Sell
-47
Closed -$9K – 14438
2022
Q2 		$9K Sell
47
-45
-49% -$14.5K ﹤0.01% 12538
2022
Q1 		$40K Sell
92
-66
-42% -$31.9K ﹤0.01% 12410
2021
Q4 		$115K Buy
+158
New +$106K ﹤0.01% 12043
2021
Q2 		– Sell
-32
Closed -$43.9K – 13469
2021
Q1 		$44K Buy
+32
New +$42.9K ﹤0.01% 12063
2020
Q4 		– Sell
-31
Closed -$10K – 11910
2020
Q3 		$10K Buy
+31
New +$11.7K ﹤0.01% 10422
2019
Q2 		– Sell
-9
Closed -$25K – 11010
2019
Q1 		$25K Buy
9
+2
+29% +$6.43K ﹤0.01% 8569
2018
Q4 		$26K Buy
+7
New +$35.8K ﹤0.01% 8639
2018
Q1 		– Sell
-1
Closed -$33K – 10404
2017
Q4 		$33K Buy
+1
New +$54.4K ﹤0.01% 9007
2017
Q1 		– Hold
0
– -$36K – 10236
2016
Q4 		– Hold
0
– – – 9356
2016
Q3 		– Hold
0
– – – 8161

Other funds holding CYTO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's CYTO Position: Q4 2023 in Review

Susquehanna International Group sold out of Altamira Therapeutics Ltd (CYTO) in Q4 2023, closing a stake of 509 shares — an estimated $2.46K sold.

Susquehanna International Group first reported a position in CYTO in Q4 2017 and held it in 9 quarters. The position peaked at $115K in Q4 2021. 4 funds tracked by Wall St. Rank hold CYTO as of Q4 2023.

  • Susquehanna International Group reported no remaining Altamira Therapeutics Ltd position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 509 Altamira Therapeutics Ltd shares in Q4 2023, an estimated $2.46K.
  • Susquehanna International Group first reported a position in Altamira Therapeutics Ltd in Q4 2017 and held it in 9 quarters.
  • Susquehanna International Group's Altamira Therapeutics Ltd position peaked at $115K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Altamira Therapeutics Ltd as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.